This appears to be the case for Tissue Factor Pathway Inhibitor 2 (TFPI2), as methylated, and silenced TFPI2 DNA is used as a biomarker for metastatic cancer [7]. The gene discussed is TFPI2; the disease is metastatic malignant neoplasm.